Ovarian Carcinosarcoma
📧 Sign up to get email alerts when something new happens for Ovarian Carcinosarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib [Phase 2, Phase 3]
A phase 2/3 trial evaluating Niraparib in combination with anti-PD-1 therapy for recurrent ovarian carcinosarcoma and endometrial carcinosar…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas [Phase 2]
Phase 2 study of LN-145 (LN-145-S1) in relapsed or refractory ovarian cancer, triple-negative breast cancer, anaplastic thyroid cancer, oste…
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma [Phase 2]
A Phase 2 trial investigating the combination of eribulin and pembrolizumab in patients with ovarian carcinosarcoma or uterine carcinosarcom…